A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology.

Lazar V, Zhang B, Magidi S, Le Tourneau C, Raymond E, Ducreux M, Bresson C, Raynaud J, Wunder F, Onn A, Felip E, Tabernero J, Batist G, Kurzrock R, Rubin E, Schilsky RL

Open source

DOI
10.1177/17588359231156382
Published
2023
Container
Therapeutic advances in medical oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/17588359231156382,
  title = {A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology.},
  author = {Lazar V and Zhang B and Magidi S and Le Tourneau C and Raymond E and Ducreux M and Bresson C and Raynaud J and Wunder F and Onn A and Felip E and Tabernero J and Batist G and Kurzrock R and Rubin E and Schilsky RL},
  year = {2023},
  journal = {Therapeutic advances in medical oncology},
  doi = {10.1177/17588359231156382},
  url = {https://doi.org/10.1177/17588359231156382}
}

RIS

TY  - JOUR
TI  - A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology.
AU  - Lazar V
AU  - Zhang B
AU  - Magidi S
AU  - Le Tourneau C
AU  - Raymond E
AU  - Ducreux M
AU  - Bresson C
AU  - Raynaud J
AU  - Wunder F
AU  - Onn A
AU  - Felip E
AU  - Tabernero J
AU  - Batist G
AU  - Kurzrock R
AU  - Rubin E
AU  - Schilsky RL
PY  - 2023
JO  - Therapeutic advances in medical oncology
DO  - 10.1177/17588359231156382
UR  - https://doi.org/10.1177/17588359231156382
ER  - 

APA

V, L., B, Z., S, M., C, L. T., E, R., M, D., C, B., J, R., F, W., A, O., E, F., J, T., G, B., R, K., E, R., & RL, S. (2023). A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology.. Therapeutic advances in medical oncology. https://doi.org/10.1177/17588359231156382

Source records